RESUMO
OPINION STATEMENT: Adults with congenital heart disease represent a growing population. Now, more adults are living with congenital heart disease than children. Thus, adult cardiologists are likely to care for patients with either new diagnoses of congenital heart defects or complications of previously diagnosed defects or their interventions. In the present article, we review congenital conditions that lead to left-sided pressure overload states, specifically, subaortic stenosis, aortic stenosis, and coarctation of the aorta. We discuss the anatomy, epidemiology, and diagnosis of these specific lesions and review the current literature for management considerations.
RESUMO
Recent work has highlighted the strong relationships among obesity, diabetes, and the metabolic syndrome as causes of low urinary pH. Low urinary pH in turn is the major urinary risk factor for uric acid stones. Unlike calcium stones, uric acid stones can be dissolved and easily prevented with adequate urinary alkalinization. Recognizing the relevant risk factors should lead to increased identification of these radiolucent stones. The cornerstone of therapy is raising urinary pH; xanthine dehydrogenase inhibitors should be used only when urinary alkalinization cannot be achieved.
Assuntos
Gota/urina , Ácido Úrico/urina , Urolitíase/metabolismo , Inibidores Enzimáticos/uso terapêutico , Humanos , Concentração de Íons de Hidrogênio , Fatores de Risco , Urolitíase/prevenção & controle , Xantina Desidrogenase/antagonistas & inibidoresRESUMO
Alzheimer's disease constitutes a rising threat to public health. Despite extensive research in cellular and animal models, identifying the pathogenic agent present in the human brain and showing that it confers key features of Alzheimer's disease has not been achieved. We extracted soluble amyloid-beta protein (Abeta) oligomers directly from the cerebral cortex of subjects with Alzheimer's disease. The oligomers potently inhibited long-term potentiation (LTP), enhanced long-term depression (LTD) and reduced dendritic spine density in normal rodent hippocampus. Soluble Abeta from Alzheimer's disease brain also disrupted the memory of a learned behavior in normal rats. These various effects were specifically attributable to Abeta dimers. Mechanistically, metabotropic glutamate receptors were required for the LTD enhancement, and N-methyl D-aspartate receptors were required for the spine loss. Co-administering antibodies to the Abeta N-terminus prevented the LTP and LTD deficits, whereas antibodies to the midregion or C-terminus were less effective. Insoluble amyloid plaque cores from Alzheimer's disease cortex did not impair LTP unless they were first solubilized to release Abeta dimers, suggesting that plaque cores are largely inactive but sequester Abeta dimers that are synaptotoxic. We conclude that soluble Abeta oligomers extracted from Alzheimer's disease brains potently impair synapse structure and function and that dimers are the smallest synaptotoxic species.